Patients over the age of 50 have an increased risk of mortality following hip fracture, which is dependent on factors such as health and post-fracture comorbidities. Findings from a meta-analysis ...

We conducted a 10-year, prospective, double-blind, randomized, placebo-controlled trial involving early postmenopausal women (50 to 60 years of age ... spine or hip fracture, use of any ...

For early postmenopausal women, zoledronate administered at baseline and five years is effective for preventing morphometric ...